XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
segment
Sep. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2016
USD ($)
New Accounting Pronouncement, Early Adoption [Line Items]                
Restricted cash $ 100,000   $ 100,000     $ 100,000    
Joint venture quarterly promotion fee cap 5.00%   5.00%          
Revenue $ 10,775,000 $ 10,439,000 $ 29,307,000 $ 30,173,000        
Advertising Expense 300,000 400,000 $ 900,000 1,100,000        
Cost of revenue   400,000   1,100,000        
Number of operating segments | segment     1          
Janssen (SIMPONI)                
New Accounting Pronouncement, Early Adoption [Line Items]                
Revenue 1,300,000 $ 400,000 $ 3,400,000 $ 800,000        
Forecast                
New Accounting Pronouncement, Early Adoption [Line Items]                
Joint venture quarterly promotion fee cap         5.00%      
Minimum                
New Accounting Pronouncement, Early Adoption [Line Items]                
Joint venture, quarterly promotion fee per prescription             $ 750  
Joint venture, quarterly promotion fee 300,000   300,000          
Minimum | Forecast                
New Accounting Pronouncement, Early Adoption [Line Items]                
Joint venture, quarterly promotion fee         $ 300,000      
Maximum                
New Accounting Pronouncement, Early Adoption [Line Items]                
Joint venture, quarterly promotion fee per prescription             $ 1,250  
Other assets                
New Accounting Pronouncement, Early Adoption [Line Items]                
Restricted cash               $ 100,000
Shipping and Handling                
New Accounting Pronouncement, Early Adoption [Line Items]                
Cost of revenue $ 400,000   $ 1,100,000          
Revenue Benchmark | Product Concentration Risk | AVISE CTD Test                
New Accounting Pronouncement, Early Adoption [Line Items]                
Percent of total revenue 68.00% 83.00% 71.00% 83.00%        
Revenue Benchmark | Supplier Concentration Risk | Two Suppliers                
New Accounting Pronouncement, Early Adoption [Line Items]                
Percent of total revenue 98.00% 97.00% 97.00% 96.00%